Media Resources

2014
1 February

Policy Brief 5 – Sales Taxes on Medicines
1 February

Policy Brief 2 – The Role of Health Insurance in the Cost-effective Use of Medicines
1 February

Working Paper 1 – External Reference Pricing
1 February

Policy Brief 4 – Competition Policy
1 February

Policy Brief 1 – External Reference Pricing
1 February

Working Paper 2 – The Role of Health Insurance in the Cost-Effective Use of Medicines
1 February

Working Paper 3: The Regulation of Mark-ups in the Pharmaceutical Supply Chain
1 January

Understanding and Responding To Medicines Promotion
2013
6 October

Transparency of Clinical Trial Data on Medicines in the EU
1 July

LAC-Global Alliance Statement on Trans-Pacific Partnership and Access to Affordable Medicines
21 June

NGOs Condemn the EU Press Release on TRIPS Extension for Least Developed Countries
16 April

Comprendre la promotion pharmaceutique et y répondre: Un manuel pratique
9 April

EU-India free trade deal puts millions of lives at risk
1 March

2012 Annual Report
1 March

2012 Financial Statements
2012
16 July

ACTA is dead, long live ACTA? ACTA-like measures still in EU IP policies
8 June

Time for the final push: Say “No” to ACTA – again
15 May

EU Parliament Says No and No Again to EMA: Independent Groups Echo Decision
28 March

Big Pharma Spends Over €40 Million per Year Lobbying in the EU, Dwarfing Public Health NGOs
26 March

Civil Society Calls on Members of the European Parliament to Condemn ACTA
20 March

Divide and Conquer: A look behind the scenes of the EU pharmaceutical industry lobby
10 January

Business Conduct Guidelines
10 January

Complaints Procedure (EN)
1 January

Unlocking the Mysteries of Access to Clinical Trials Data in the EU
2011
14 October

Statement on Medicines Patent Pool
1 September

Universal Access to Medicines for Non-Communicable Diseases
8 July

Drop in Pay-for-Delay Good for Access to Medicines in Europe
20 May

Statement on Conflicts of Interests delivered at WHA
18 March

Statement on EU India and EU Mercosur Free-Trade Negotiations
21 January

Medicines pay-for-delay back under the microscope